Richardson Financial Services’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$128K Buy
677
+67
+11% +$12.6K 0.07% 204
2026
Q1
$120K Sell
610
-29
-5% -$5.59K 0.08% 202
2025
Q4
$118K Buy
639
+79
+14% +$13.9K 0.04% 212
2025
Q3
$85.8K Buy
560
+361
+181% +$54.6K 0.05% 224
2025
Q2
$28.4K Buy
199
+74
+59% +$10.4K 0.02% 310
2025
Q1
$18.3K Buy
125
+97
+346% +$14K 0.01% 329
2024
Q4
$3.67K Sell
28
-30
-52% -$4.2K ﹤0.01% 473
2024
Q3
$8.96K Buy
58
+28
+93% +$4.52K 0.01% 408
2024
Q2
$4.68K Sell
30
-7
-19% -$1.05K ﹤0.01% 445
2024
Q1
$4.95K Buy
+37
New +$4.9K ﹤0.01% 464

Other funds holding AZN

Richardson Financial Services's AZN Position: Q2 2026 in Review

Richardson Financial Services increased its AstraZeneca (AZN) stake by 11% in Q2 2026, buying an estimated $12.6K and bringing the position to 677 shares worth $128K. The position accounts for 0.07% of the portfolio, ranked #204.

Richardson Financial Services first reported a position in AZN in Q1 2024 and has held it in 10 quarters since. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Richardson Financial Services held 677 shares of AstraZeneca worth $128K as of Q2 2026.
  • Richardson Financial Services bought 67 AstraZeneca shares in Q2 2026, an estimated $12.6K.
  • AstraZeneca made up 0.07% of Richardson Financial Services's portfolio in Q2 2026, its #204 holding.
  • Richardson Financial Services first reported a position in AstraZeneca in Q1 2024 and has held it in 10 quarters since.
  • 1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Richardson Financial Services's 13F filing for Q2 2026, filed 10 Aug 2026.